Numerous randomised controlled trials have demonstrated the benefit of radiation therapy in patients with newly diagnosed glioblastoma and it has been the cornerstone of treatment for decades. The aims of this review are to (1) Briefly outline the historical studies which resulted in radiation being the current standard of care as used in the Stupp et al. trial (2) Discuss the evolving role of radiation therapy in the management of elderly patients (3) Review the current evidence and ongoing studies of radiation use in the recurrent/salvage setting and (4) Discuss the continuing controversies of volume delineation in the planning of radiation delivery.
Description
The evolving roles and controversies of radiotherapy in the treatment of glioblastoma. - PubMed - NCBI
%0 Journal Article
%1 Hau:2016:J-Med-Radiat-Sci:27350891
%A Hau, E
%A Shen, H
%A Clark, C
%A Graham, P H
%A Koh, E S
%A L McDonald, K
%D 2016
%J J Med Radiat Sci
%K glioblastoma radiotherapy therapy
%N 2
%P 114-123
%R 10.1002/jmrs.149
%T The evolving roles and controversies of radiotherapy in the treatment of glioblastoma
%U https://www.ncbi.nlm.nih.gov/pubmed/27350891
%V 63
%X Numerous randomised controlled trials have demonstrated the benefit of radiation therapy in patients with newly diagnosed glioblastoma and it has been the cornerstone of treatment for decades. The aims of this review are to (1) Briefly outline the historical studies which resulted in radiation being the current standard of care as used in the Stupp et al. trial (2) Discuss the evolving role of radiation therapy in the management of elderly patients (3) Review the current evidence and ongoing studies of radiation use in the recurrent/salvage setting and (4) Discuss the continuing controversies of volume delineation in the planning of radiation delivery.
@article{Hau:2016:J-Med-Radiat-Sci:27350891,
abstract = {Numerous randomised controlled trials have demonstrated the benefit of radiation therapy in patients with newly diagnosed glioblastoma and it has been the cornerstone of treatment for decades. The aims of this review are to (1) Briefly outline the historical studies which resulted in radiation being the current standard of care as used in the Stupp et al. trial (2) Discuss the evolving role of radiation therapy in the management of elderly patients (3) Review the current evidence and ongoing studies of radiation use in the recurrent/salvage setting and (4) Discuss the continuing controversies of volume delineation in the planning of radiation delivery.},
added-at = {2017-04-17T17:37:08.000+0200},
author = {Hau, E and Shen, H and Clark, C and Graham, P H and Koh, E S and L McDonald, K},
biburl = {https://www.bibsonomy.org/bibtex/224591187f53878c054e0164d46ffce67/marcsaric},
description = {The evolving roles and controversies of radiotherapy in the treatment of glioblastoma. - PubMed - NCBI},
doi = {10.1002/jmrs.149},
interhash = {e03e06c1c69703a24a624a578a15316a},
intrahash = {24591187f53878c054e0164d46ffce67},
journal = {J Med Radiat Sci},
keywords = {glioblastoma radiotherapy therapy},
month = jun,
number = 2,
pages = {114-123},
pmid = {27350891},
timestamp = {2017-05-05T22:14:49.000+0200},
title = {The evolving roles and controversies of radiotherapy in the treatment of glioblastoma},
url = {https://www.ncbi.nlm.nih.gov/pubmed/27350891},
volume = 63,
year = 2016
}